CLOBAZAM News

← Back to News Overview

---

CLOBAZAM currently has 0 news articles, with 12 predicted indications.

This page combines the AI-predicted indications for CLOBAZAM with the latest health news. Indications highlighted in orange have recent news coverage.

Drug Information

• Evidence level: L5
• Predicted indications (12):
  • Lennox-Gastaut syndrome (99.0%)
  • cutis verticis gyrata (99.0%)
  • febrile infection-related epilepsy syndrome (99.8%)
  • perioral myoclonia with absences (99.8%)
  • cryptogenic late-onset epileptic spasms (99.8%)
  • atypical childhood epilepsy with centrotemporal spikes (99.8%)
  • photosensitive occipital lobe epilepsy (99.8%)
  • childhood onset epileptic encephalopathy (99.6%)
  • benign occipital epilepsy (99.6%)
  • early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation (99.4%)
  • restless legs syndrome (99.3%)
  • polymicrogyria with optic nerve hypoplasia (99.1%)

View full drug report →

Related News (0)

No related news yet. When news mentions this drug, it will be collected and shown here automatically.

Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.